Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immune mechanism and therapeutic drug for gastrointestinal diseases

A technology for gastrointestinal diseases and drugs, applied in the field of gastrointestinal diseases, can solve the problems of lack of specific treatment methods for functional gastrointestinal diseases, improve the level of clinical personalized diagnosis and treatment, and promote accurate classification type effect

Pending Publication Date: 2022-05-06
GUANGZHOU WOMEN AND CHILDRENS MEDICAL CENTER
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Treatment of functional gastrointestinal disorders in children lacks specific therapeutic approaches due to lack of understanding of etiology and pathogenesis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune mechanism and therapeutic drug for gastrointestinal diseases
  • Immune mechanism and therapeutic drug for gastrointestinal diseases
  • Immune mechanism and therapeutic drug for gastrointestinal diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Example 1. Single-cell sequencing and bioinformatic analysis of cells in the colonic mucosa of children with colitis and controls

[0101] I. Research program:

[0102] (1) Obtain colonic mucosal tissue from children with control and non-infectious gastrointestinal diseases, and obtain single cell suspension;

[0103] (2) After surface staining, four subpopulations of T, B, non-TB lymphocytes, and non-lymphocytes were sorted by flow cytometry;

[0104] (3) Single-cell transcriptome analysis for each cell subpopulation;

[0105] (4) Single-cell sequencing results, analyzing the clustering characteristics of immune cell subsets, and establishing the composition and transcriptional characteristics of colonic mucosal immune cells;

[0106] (5) Determine the specific functional characteristics of cell subgroups through signal pathway enrichment analysis. Identify cell-type-specific highly expressed transcription factors, and establish transcription factor regulatory netwo...

Embodiment 2

[0130] Example 2. Clinical trials and evaluation of dipyridamole in the treatment of colitis in children

[0131] The following study was carried out on the colonic mucosa of the patients described in Example 1, ie children with non-eosinophilic colitis and eosinophilic colitis (67 and 23 cases, respectively), and 28 control children. Please refer to Table 3 for the condition of the patients.

[0132] Table 3. Clinical characteristics of control and disease groups

[0133]

[0134]

[0135]

[0136] *P<0.01 and **P<0.001 are compared with the control group; #P<0.01 and ##P<0.001 are compared with the non-eosinophilic colitis group.

[0137] It was investigated whether reduced expression of CD39 in the colonic mucosa exacerbates inflammation by promoting ATP and ADP accumulation. First, we correlated CD39 expression on T cells with ATP and ADP excretion in colon biopsies stored overnight. In these cases, ATP cannot be detected. However, the decreased expression of ...

Embodiment 3

[0155] The effect of dipyridamole in DSS (dextran sulfate sodium, dextran sulphate sodium)-induced acute colitis model

[0156] mouse

[0157] Six- to eight-week-old male C57BL / 6J mice (20-22 g) were purchased from Guangzhou University of Traditional Chinese Medicine. The mice were given regular food and water before the experiment. Weight-matched mice were used in all studies. Animal studies were approved by the Animal Care and Use Committee of Guangzhou Medical University (permit number: 2019-471) and performed according to institutional guidelines.

[0158] DSS-induced acute colitis

[0159]Mice were pretreated with dipyridamole (10 mg / kg body weight, Sigma-Aldrich) or vehicle (2% DMSO, 10% ethanol, 88% corn oil) twice daily for 3 days, followed by DSS (36,000– 50,000MW), MPBiomedicals) were added to their drinking water (3%) for 9 days. Control mice were given regular food and water. Mice were monitored daily and euthanized if they lost more than 20% of their body we...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses an immune mechanism and a therapeutic drug for intestinal diseases. The present invention relates to immune mechanisms of gastrointestinal diseases, such as non-infectious gastrointestinal diseases, including non-infectious gastrointestinal diseases in children, and to new uses of phosphodiesterase inhibitors and / or antiplatelet drugs in the treatment of gastrointestinal diseases such as non-infectious gastrointestinal diseases.

Description

technical field [0001] The present invention relates to gastrointestinal diseases, such as infectious or non-infectious gastrointestinal diseases, in particular non-infectious gastrointestinal diseases, including non-infectious gastrointestinal diseases in children and the new application of PDE inhibitors and / or antiplatelet drugs in the treatment of gastrointestinal diseases, such as non-infectious gastrointestinal diseases. Background technique [0002] Gastrointestinal diseases, such as non-infectious gastrointestinal diseases, are a general term for a variety of gastrointestinal inflammatory diseases, including, for example, inflammatory gastrointestinal diseases (such as inflammatory bowel disease (inflammatory bowel disease, hereinafter Sometimes referred to simply as IBD), allergic gastrointestinal disorders (such as food allergies), and functional gastrointestinal disorders can affect people of all ages. It is also especially common in infants and young children, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K45/06A61K31/519A61P1/00
CPCA61K45/00A61K45/06A61K31/519A61P1/00G01N2800/065G01N33/56972G01N2333/525G01N2333/70596G01N33/86G01N2333/916G01N33/6893G01N2800/222
Inventor 张玉霞杨敏黄冰陈章华张莉白凡龚四堂
Owner GUANGZHOU WOMEN AND CHILDRENS MEDICAL CENTER
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com